undamentalytics Newsletter
Sign in

Citrotech Inc. revenue

Citrotech Inc.'s revenue was $2.4m in fiscal 2025, up 194.6% on the year before. Since fiscal 2022 ($62,732) it has grown at a compound 236.1% a year. Over the last twelve months it was $1.3m.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue0635218082,3811,350
Growth on the year before——+730.0%+55.3%+194.6%—
Gross profit2061387153531−70
Gross margin—97.0%74.4%18.9%22.3%−5.2%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Products Sale $1.3M 56.7% ▲ 115.4%
Product Installation Service $1M 43.3% ▲ 467.2%

From Citrotech Inc.'s 10-K filed March 30, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Specialty Chemicals: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Citrotech Inc. $1.3m -26.4% 134.1%
Senestech, Inc. $2.4m 13.4% 29.8%
Park Ha Biological Technology Co., Ltd. $2.5m 6.0% —
Research Frontiers Inc $654,232 -46.5% -2.9%
Zone Frontier Inc. $3.4m 64.2% —
J-star Holding Co., Ltd. $9.9m -43.5% —

Compare with peers

Head to head: CITR vs SNESBYAH vs CITRCITR vs REFRCITR vs ZONE

More: Specialty Chemicals stocks compared, Materials sector, rankings of US companies

Figures from Citrotech Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Citrotech Inc.